MoneyWorks4Me

RPG Life Sciences - Quaterly Results

30 Apr 2024 Evaluate
The revenue zoomed 7.17% to Rs. 1269.90 millions for the quarter ended March 2024 as compared to Rs. 1184.90 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended March 2024 rise to 27.92% to Rs. 132.40  millions  compared to R. 103.50 millions in corresponding previous quarter.The company reported a good operating profit of 223.70 millions compared to 177.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1269.90 1184.90 7.17 5820.50 5128.10 13.50 5820.50 5128.10 13.50
Other Income 16.50 18.40 -10.33 72.10 48.00 50.21 72.10 48.00 50.21
PBIDT 223.70 177.50 26.03 1353.60 1074.90 25.93 1353.60 1074.90 25.93
Interest 1.40 0.50 180.00 4.50 3.10 45.16 4.50 3.10 45.16
PBDT 222.30 177.00 25.59 1349.10 1071.80 25.87 1349.10 1071.80 25.87
Depreciation 44.90 38.90 15.42 170.70 155.00 10.13 170.70 155.00 10.13
PBT 177.40 138.10 28.46 1178.40 916.80 28.53 1178.40 916.80 28.53
TAX 45.00 34.60 30.06 301.80 240.40 25.54 301.80 240.40 25.54
Deferred Tax -9.50 -2.30 313.04 -23.60 -3.10 661.29 -23.60 -3.10 661.29
PAT 132.40 103.50 27.92 876.60 676.40 29.60 876.60 676.40 29.60
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 17.62 14.98 17.59 23.26 20.96 10.95 23.26 20.96 10.95
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..